Medpace Holdings, Inc.
- Stock
- Ticker MEDP
- ISIN US58506Q1094
- Nasdaq
Performance, volatility and drawdowns of Medpace Holdings, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $169,878. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −42.9% in 04/2022, measured from the peak in 12/2021. It took 13 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 537 | 559 | 603 | 660 | 708 | 707 | 707 | 716 |
| Operating income | 125 | 114 | 126 | 142 | 153 | 142 | 147 | 166 |
| EBITDA | 133 | 120 | 133 | 149 | 160 | 148 | 153 | 172 |
| Net income | 117 | 115 | 90 | 111 | 135 | 124 | 121 | 137 |
| Earnings per share | 3.67 | 3.67 | 3.10 | 3.86 | 4.64 | 4.28 | 4.25 | 4.84 |
| Balance sheet | ||||||||
| Total assets | 2,101 | 1,897 | 1,572 | 1,753 | 1,975 | 2,130 | 2,057 | 2,303 |
| Liabilities | 1,275 | 1,304 | 1,399 | 1,459 | 1,516 | 1,531 | 1,623 | 1,718 |
| Equity | 826 | 594 | 172 | 294 | 459 | 598 | 434 | 585 |
| Cash | 669 | 441 | 46 | 285 | 497 | 653 | 503 | 705 |
| Cash flow | ||||||||
| Operating cash flow | 191 | 126 | 149 | 246 | 193 | 152 | 162 | 217 |
| Capital expenditure | -7.6 | -10.0 | -6.1 | -11 | -4.5 | -6.8 | -24 | -20 |
| Free cash flow | 183 | 116 | 142 | 235 | 188 | 145 | 138 | 196 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +69.1%, weakest 2022 at −2.4%. 8 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 22 Oct 2026 | $4.84 |
| 23 Jul 2026 | $4.25 |
| 23 Apr 2026 | $4.28 |
| 10 Feb 2026 | $4.64 |
| 23 Oct 2025 | $3.86 |
| 22 Jul 2025 | $3.10 |
| 22 Apr 2025 | $3.67 |
| 11 Feb 2025 | $3.67 |
| 22 Oct 2024 | $3.01 |
| 23 Jul 2024 | $2.75 |
| 23 Apr 2024 | $3.20 |
| 13 Feb 2024 | $2.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €15bn
- Market cap in trading currency
- $17.1bn
- Enterprise value
- $16.4bn
- P/E
- 33.9
- P/S
- 6.02
- P/B
- 29.20
- EV/Sales
- 5.77
- EV/EBITDA
- 25.8
- Earnings yield
- 2.9%
- FCF yield
- 3.9%
Results (last four quarters)
- Revenue
- $2.84bn
- Gross profit
- –
- EBITDA
- $634m
- Net income
- $518m
- Earnings per share
- $18.01
- Revenue per share
- $101.47
- Revenue growth
- +8.5%
- Earnings growth
- +23.7%
Profitability
- Gross margin
- –
- Operating margin
- 21.4%
- Net margin
- 18.2%
- Return on equity
- 117.9%
- Return on assets
- 22.5%
Balance sheet and cash flow
- Cash
- $705m
- Cash per share
- $25.22
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 0.83
- Book value per share
- $20.91
- Operating cash flow
- $723m
- Free cash flow
- $668m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 28.0m
- Volume
- 236,648
- Avg. volume 3 months
- 258,149
- Relative volume
- 0.9
Price and technicals
- Price
- $610.54
- 1 day
- −3.7%
- 52-week high
- $692.68
- 52-week low
- $393.42
- Distance to 52-week high
- −11.9%
- Distance to 52-week low
- +55.2%
- Distance to 50-day line
- −3.8%
- Distance to 200-day line
- +14.4%
- RSI (14)
- 38
- Volatility 1M
- 33.8%
Performance
- 1 week
- −6.6%
- 1 month
- −6.6%
- 3 months
- −1.5%
- 6 months
- +41.1%
- YTD
- +8.7%
- 1 year
- +3.1%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MEDP performed since 11/2016?
$10,000 grew to $169,878 by 20 Nov 2026, which is +32.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MEDP?
Volatility was 41.8% per year, measured on monthly returns. The largest decline from a peak was −42.9%, with the low in 04/2022.
How does MEDP compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, MEDP returned +32.8% at 41.8%. The correlation of monthly returns was 0.41; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.